Skip to main content

and
  1. Article

    Open Access

    Correction to: The Italian tremor Network (TITAN): rationale, design and preliminary findings

    Roberto Erro, Andrea Pilotto, Marcello Esposito, Enrica Olivola in Neurological Sciences (2022)

  2. Article

    Open Access

    Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?

    The aim of this study is to assess changes in the body distribution and the semeiology of functional motor disorder (FMD) in patients who reported only one or more than one body site affected at FMD onset. Dat...

    Tommaso Ercoli, Michele Tinazzi, Christian Geroin in Journal of Neural Transmission (2022)

  3. Article

    Open Access

    The Italian tremor Network (TITAN): rationale, design and preliminary findings

    The recently released classification has revised the nosology of tremor, defining essential tremor (ET) as a syndrome and fueling an enlightened debate about some newly conceptualized entities such as ET-plus....

    Roberto Erro, Andrea Pilotto, Marcello Esposito, Enrica Olivola in Neurological Sciences (2022)

  4. Article

    Open Access

    Functional motor phenotypes: to lump or to split?

    Functional motor disorders (FMDs) are usually categorized according to the predominant phenomenology; however, it is unclear whether this phenotypic classification mirrors the underlying pathophysiologic mecha...

    Michele Tinazzi, Christian Geroin, Enrico Marcuzzo, Sofia Cuoco in Journal of Neurology (2021)

  5. Article

    Open Access

    An attempt to dissect a peripheral marker based on cell pathology in Parkinson's disease

    Peripheral markers in Parkinson’s disease (PD) represent a hot issue to provide early diagnosis and assess disease progression. The gold standard marker of PD should feature the same reliability as the pathoge...

    Francesca Biagioni, Rosangela Ferese, Filippo Sean Giorgi in Journal of Neural Transmission (2021)

  6. Article

    Open Access

    Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age

    Levodopa–Carbidopa Intrajejunal gel (LCIG) infusion is an effective intervention for people with advanced Parkinson’s disease (PD). Although age may not be a limiting factor for LCIG implant, no data are avail...

    Francesca Morgante, Valentina Oppo, Margherita Fabbri in Journal of Neurology (2021)

  7. No Access

    Article

    Validation of the Italian version of the PSP Quality of Life questionnaire

    Progressive supranuclear palsy (PSP) is a rare rapidly progressive, neurodegenerative disease characterized by falls and ocular movement disturbances. The use of health-related quality of life (HR-QoL) measur...

    Marina Picillo, Sofia Cuoco, Marianna Amboni in Neurological Sciences (2019)

  8. No Access

    Article

    Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy

    Progressive supranuclear palsy (PSP) is a rare, rapidly progressive, neurodegenerative disease characterized by falls and ocular movement disturbances. Caring for a partner or relative who suffers from PSP ent...

    Marina Picillo, Sofia Cuoco, Marianna Amboni in Neurological Sciences (2019)

  9. Article

    Correction to: Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies

    The published version of this article unfortunately contained a mistake in Table 2. CGI-S and CGI-I values has been interchanged. The Table is corrected here.

    Enrica Olivola, Alfonso Fasano, Sara Varanese, Francesco Lena in Neurological Sciences (2019)

  10. No Access

    Article

    Continuous subcutaneous apomorphine infusion in Parkinson’s disease: causes of discontinuation and subsequent treatment strategies

    Continuous subcutaneous apomorphine infusion (CSAI) is a well-recognized therapeutic option for the management of motor fluctuations in Parkinson’s disease (PD), although clinical experience suggests that most...

    Enrica Olivola, Alfonso Fasano, Sara Varanese, Francesco Lena in Neurological Sciences (2019)

  11. No Access

    Article

    Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson’s disease

    Excessive daytime sleepiness (EDS) may represent a disabling non-motor symptom in patients affected by Parkinson’s disease (PD). This is a secondary analysis of a previous study documenting the improvement of ...

    Claudio Liguori, Nicola Biagio Mercuri, Maria Albanese in Journal of Neurology (2019)

  12. No Access

    Article

    Does fatigue in Parkinson’s disease correlate with autonomic nervous system dysfunction?

    Despite its negative impact on quality of life, fatigue in Parkinson’s disease (PD) remains an under-recognized issue and the underlying pathology is undetermined.

    Enrica Olivola, Livia Brusa, Camilla Rocchi, Orazio Schillaci in Neurological Sciences (2018)

  13. No Access

    Article

    Successful subthalamic stimulation, but levodopa-induced dystonia, in a genetic Parkinson’s disease

    Recently, it is under scrutiny the possibility to anticipate the stereotactic implantation of the subthalamic nucleus (STN) even in relatively mild Parkinson’s disease (PD) patients with an unsatisfying respon...

    Alessandro Stefani, Francesco Marzetti, Mariangela Pierantozzi in Neurological Sciences (2013)

  14. No Access

    Article

    CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD

    Dementia has become a relevant problem associated with the elderly in our countries. Increased interest in the field has yielded a copious literature, so far mostly centered on Alzheimer’s dementia. Cerebrospi...

    Alessandro Stefani, Livia Brusa, Enrica Olivola in Journal of Neural Transmission (2012)